The Hebei branch of the China FDA has ordered Hong Kong-listed Alibaba Health Information Technology (Ali Health) to halt sales of OTC drugs via vendors on its Tmall platform.
Alibaba Health Information Technology, or Ali Health, has a new plan to work with a network of 65 drugstore chains in China that marks the latest step to get e-commerce drug sales flowing in the country.
